Effects of etodolac, indomethacin and sodium salicylate on canine neutrophil function.
Thomsen
M K
MK
Department of Pharmacology, Leo Pharmaceutical Products, Ballerup, Denmark.
Skak-Nielsen
T
T
Ahnfelt-Rønne
I
I
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D004285:Dogs; D017308:Etodolac; D066298:In Vitro Techniques; D007210:Indoleacetic Acids / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects*; D010196:Pancreatic Elastase / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D012459:Salicylates / Q000494:pharmacology; D020156:Salicylic Acid; D013481:Superoxides / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007210:Indoleacetic Acids; D012459:Salicylates; D013481:Superoxides; D017308:Etodolac; D010196:Pancreatic Elastase; D020156:Salicylic Acid; D007213:Indomethacin